Postoperative Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Postoperative Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: A 6 Months Double Blind Trial to Prevent PONV in Laparoscopic Cholecystectomy [Phase 2]
A Phase 2 double-blind trial evaluating prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy …
-
FDA approval · 2022-08-22FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Natco Pharma Limited)
FDA approves a supplemental application for granisetron hydrochloride from Natco Pharma Limited.
-
FDA approval · 2022-08-12FDA Approved: APREPITANT — Supplemental Application (Golden State Medical Supply, Inc.)
FDA approved a supplemental application for APREPITANT from Golden State Medical Supply, Inc., under an ANDA.
-
CLINICAL_TRIALS trial_result · 2022-07-18Clinical Trial Update: Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia [Phase 4]
Phase 4 trial assessing whether fosaprepitant affects motor evoked and somatosensory evoked potentials under general anesthesia in postopera…
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Effect of Palonosetron, Ondansetron and Dexamethasone in the Prevention of Postoperative Nausea and Vomiting [Phase 3]
Phase 3 trial evaluating palonosetron, ondansetron, and dexamethasone for prevention of postoperative nausea and vomiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2022-06-23FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for ondansetron hydrochloride (generic ondansetron) from NorthStar Rx LLC under ANDA078776. The …
-
FDA approval · 2022-06-23FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ondansetron hydrochloride from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2022-06-14FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
FDA approved a supplemental application for ondansetron from AvPAK.
-
FDA approval · 2022-06-10FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride filed by Fresenius Kabi USA, LLC.
-
FDA approval · 2022-06-10FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride (ondansetron), a generic product manufactured by Fresenius Kabi USA, L…
-
FDA approval · 2022-05-19FDA Approved: GRANISETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for granisetron hydrochloride (granisetron) from Fresenius Kabi USA, LLC, expanding its regulatory a…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: Ramosetron on Late PONV (Postoperative Nausea and Vomiting) [Phase 4]
Phase 4 trial update on Ramosetron for postoperative nausea and vomiting in female breast cancer patients; study completed.
-
FDA approval · 2022-03-15FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approves Hospira, Inc.'s supplemental application for ondansetron, authorizing changes to the approved product.
-
FDA approval · 2022-03-15FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for ondansetron from Hospira, Inc., updating the product's approval under the ANDA.
-
FDA approval · 2022-03-11FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)
The FDA approved a supplemental application for ondansetron from JVET PHARMACEUTICALS LLC, enabling this generic product's expanded approval…
-
FDA approval · 2022-03-11FDA Approved: ONDANSETRON — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic ondansetron product from Heritage Pharmaceuticals (Avet) under the ANDA process.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: High-Dose Steroid for Knee Arthroplasty [Phase 4]
Phase 4 trial evaluating high-dose steroid for postoperative pain and nausea/vomiting after knee arthroplasty has completed.
-
FDA approval · 2022-03-01FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for a generic ondansetron hydrochloride product from Eugia US LLC under ANDA 202600. This approv…
-
FDA label_change · 2022-02-28FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron from Qilu Pharmaceutical Co., Ltd., likely resulting in labeling changes for this ge…
-
CLINICAL_TRIALS trial_result · 2022-02-18Clinical Trial Update: Haloperidol and Dexamethasone Towards Postoperative Nausea and Pain in Adult After Laparoscopy [Phase 4]
Phase 4 trial update on haloperidol and dexamethasone for postoperative nausea and pain after laparoscopy (completed).
-
CLINICAL_TRIALS trial_result · 2022-02-08Clinical Trial Update: The Effect of Preoperative Oral Dexamethasone Supplementation on the Outcome of Thyroidectomised Patients. [Phase 4]
Phase 4 trial investigating whether preoperative oral dexamethasone supplementation influences outcomes after thyroidectomy, including posto…
-
CLINICAL_TRIALS trial_result · 2022-01-13Clinical Trial Update: Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluated pre-operative olanzapine as a prophylactic antiemetic in oncologic patients undergoing surgery, w…
-
FDA approval · 2022-01-05FDA Approved: BARHEMSYS — Supplemental Application (Acacia Pharma Ltd)
The FDA is processing a supplemental application for BARHEMSYS (amisulpride) from Acacia Pharma Ltd.
-
FDA approval · 2021-11-29FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Chartwell RX, LLC)
FDA approved chlorpromazine hydrochloride from Chartwell RX, LLC under an original ANDA for generic use.
-
FDA approval · 2021-11-12FDA Approved: PALONOSETRON HYDROCHLORIDE — Original Application (Baxter Healthcare Corporation)
FDA approved palonosetron hydrochloride from Baxter Healthcare Corporation under an original application. The drug is indicated to prevent c…